Medical Assessment After Self-Managed Abortion

Libby Wetterer, MD,
Department of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Christina Shenko, MD, FAAFP,
Middlesex Health Family Medicine Residency, Middletown, Connecticut
Linda Prine, MD, FAAFP,
Department of Family Medicine and Community Health, Mount Sinai Medical Center, New York, New York

American Family Physician. 2023;108(5):519-522.

Author disclosures: Dr. Wetterer is in the Physicians for Reproductive Health Leadership Training Academy; Dr. Shenko is a volunteer physician with the Miscarriage and Abortion Hotline; and Dr. Prine is on the leadership team of the Miscarriage and Abortion Hotline and is the executive director of the Abortion Coalition for Telemedicine Access.

Case Scenario

M.A. is a 24-year-old patient who presents to my office two weeks after using abortion pills that she ordered online because abortion is now illegal in this state. M.A. reports that she took 200 mg of mifepristone orally 10 weeks after her last menstrual period. Twenty-four hours later, she took four misoprostol (Cytotec) pills buccally. When nothing happened, she stated that she took another misoprostol dose, after which she experienced heavy bleeding and cramping. Ten days later, she is still bleeding irregularly. She is wondering whether this is normal or whether she is still pregnant. How should I answer her questions? What are my legal risks in this situation?

Commentary

The American politicolegal landscape surrounding abortion and routine pregnancy care has been changing rapidly since the 2022 Supreme Court of the United States issued its decision on Dobbs v. Jackson Women's Health Organization.1

Patients and physicians face uncertainty about how abortion and miscarriage care may be accessed and what legal liability they may face. One grassroots response has included a dramatic increase in accessing medication abortion pills outside established health care systems, such as online pharmacies, telehealth visits with physicians from other countries, or even informal networks.2,3 Patients commonly access resources such as Plan C, Mayday Health, and the Miscarriage + Abortion Hotline (833-246-2632). The hotline is staffed by more than 60 volunteer clinicians—mostly family physicians—and offers medical information via phone and text.2

Family physicians may be asked to evaluate patients who have self-managed an abortion or miscarriage without prior consultation. Studies of medication abortion provision through telemedicine have demonstrated that limited clinical evaluation before using medications for induced abortion is safe and effective; the sparse existing data around self-managed abortion echo these findings.4 Two clinical questions typically arise after self-managed abortion or miscarriage: Is the bleeding normal? and Is the abortion complete?

For the family physician, the medical assessment is identical regardless of whether the bleeding is spontaneous or induced. Treating a resolving miscarriage is the same as treating a self-managed medication abortion. Only clinically relevant information should be documented in the medical record, such as estimated gestational age, timing of bleeding, and any pregnancy symptoms before and after the bleeding.5 The use of pills to start this process does not affect subsequent treatment and may be omitted from the medical record.6

BLEEDING

It is rare for miscarriages or abortions to result in life-threatening bleeding.7 Physicians can assess anemia or bleeding as they would for any other medical scenario that might result in symptomatic anemia by asking patients about feeling faint, whether they have maintained hydration during the process, and about the number of pads that they are soaking through. Physicians who evaluate these patients in their office can consider checking a point-of-care hemoglobin level or obtaining a complete blood count. Bleeding is considered worrisome if the patient is soaking through more than two large pads per hour for two consecutive hours (e.g., four large pads in two hours); this occurrence is rare. Figure 1 provides an approach that can help physicians triage phone calls about bleeding.8

Address correspondence to Libby Wetterer, MD, at libby.wetterer@pennmedicine.upenn.edu. Reprints are not available from the authors.

Author disclosures: Dr. Wetterer is in the Physicians for Reproductive Health Leadership Training Academy; Dr. Shenko is a volunteer physician with the Miscarriage and Abortion Hotline; and Dr. Prine is on the leadership team of the Miscarriage and Abortion Hotline and is the executive director of the Abortion Coalition for Telemedicine Access.

  1. 1.Guttmacher Institute. Roe v. Wade overturned: our latest resources. Accessed September 21, 2023. https://www.guttmacher.org/abortion-rights-supreme-court
  2. 2.Miscarriage and Abortion Hotline. Accessed June 11, 2023. https://www.mahotline.org
  3. 3.Aiken ARA, Starling JE, Gomperts R. Factors associated with use of an online telemedicine service to access self-managed medical abortion in the US. JAMA Netw Open. 2021;4(5):e2111852.
  4. 4.Aiken ARA, Romanova EP, Morber JR, et al. Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: a population based study. Lancet Reg Health Am. 2022;10:100200.
  5. 5.MacNaughton H, Nothnagle M, Early J. Mifepristone and misoprostol for early pregnancy loss and medication abortion. Am Fam Physician. 2021;103(8):473-480.
  6. 6.Watson K, Paul M, Yanow S, et al. Supporting, not reporting—emergency department ethics in a post–Roe era. N Engl J Med. 2022;387(10):861-863.
  7. 7.Upadhyay UD, Johns NE, Barron R, et al. Abortion-related emergency department visits in the United States: an analysis of a national emergency department sample. BMC Med. 2018;16(1):88.
  8. 8.Reproductive Health Access Project. Algorithm for phone triage of bleeding with medication abortion. May 25, 2022. Accessed June 12, 2023. https://www.reproductiveaccess.org/resource/algorithm-phone-triage-bleeding-medication-abortion
  9. 9.Raymond EG, Tan Y-L, Grant M, et al. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing. Contraception. 2018;97(4):324-328.
  10. 10.Fleming M, Shih G, Goodman S, co-editors; TEACH Collaborative Working Group. Medication abortion: ultrasound as needed with medication abortion. TEACH: abortion training curriculum, 7th ed. UCSF Bixby Center for Global Reproductive Health; 2022. Accessed September 24, 2023. https://pressbooks.pub/workbook/chapter/ultrasound-with-medication-abortion
  11. 11.Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76(1):129-135.
  12. 12.Moseson H, Jayaweera R, Egwuatu I, et al. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls. Lancet Glob Health. 2022;10(1):e105-e113.
  13. 13.U.S. Department of Health and Human Services. HIPAA Privacy Rule and disclosures of information relating to reproductive health care. June 29, 2022. Accessed June 11, 2023. https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/phi-reproductive-health/index.html
  14. 14.If When How. Decriminalizing self-managed and supported non-clinical abortion. Report: self-care, criminalized: August 2022 preliminary findings. Accessed September 21, 2023. https://www.ifwhenhow.org/resources/self-care-criminalized-preliminary-findings
  15. 15.Cartwright AF, Tumlinson K, Upadhyay UD. Pregnancy outcomes after exposure to crisis pregnancy centers among an abortion-seeking sample recruited online. PLoS One. 2021;16(7):e0255152.
  16. 16.American College of Obstetricians and Gynecologists. Issue brief: crisis pregnancy centers. October 2022. Accessed August 16, 2023. https://www.acog.org/advocacy/abortion-is-essential/trending-issues/issue-brief-crisis-pregnancy-centers
  17. 17.Bryant AG, Swartz JJ. Why crisis pregnancy centers are legal but unethical. AMA J Ethics. 2018;20(1):269-277.
  18. 18.American College of Obstetricians and Gynecologists. Facts are important: medication abortion “reversal” is not supported by science. Accessed August 9, 2023. https://www.acog.org/advocacy/facts-are-important/medication-abortion-reversal-is-not-supported-by-science
  19. 19.Repro Legal Helpline. Abortion access: know your rights. Accessed June 11, 2023. https://www.reprolegalhelpline.org/sma-know-your-rights
  20. 20.Chary S, Pacia D, Shachar C. Abortion miscoding—legal risks for clinicians and hospital systems. JAMA. 2023;329(22): 1911-1912.

Case scenarios are written to express typical situations that family physicians may encounter; authors remain anonymous. Send scenarios to afpjournal@aafp.org. Materials are edited to retain confidentiality.

This series is coordinated by Caroline Wellbery, MD, associate deputy editor.

A collection of Curbside Consultation published in AFP is available at https://www.aafp.org/afp/curbside.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.